NCT03497741

Brief Summary

Association between plasma procalcitonin levels and positive blood cultures in critical illness patients in the ICU.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
170

participants targeted

Target at P50-P75 for all trials

Timeline
Completed

Started Oct 2017

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

October 1, 2017

Completed
6 months until next milestone

First Submitted

Initial submission to the registry

March 28, 2018

Completed
16 days until next milestone

First Posted

Study publicly available on registry

April 13, 2018

Completed
9 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 1, 2019

Completed
2 months until next milestone

Study Completion

Last participant's last visit for all outcomes

March 1, 2019

Completed
Last Updated

June 21, 2024

Status Verified

June 1, 2024

Enrollment Period

1.3 years

First QC Date

March 28, 2018

Last Update Submit

June 18, 2024

Conditions

SepsisProcalcitonin

Keywords

Intensive Care Unit

Outcome Measures

Primary Outcomes (1)

  • The predictive value of procalcitonin in blood cultures on the ICU

    This study will examine the predictive value of procalcitonin on blood cultures on the ICU. A high value of procalcitonin is a predictor for bacteremia. The predictive value: procalcitonin. Primary outcome: bacteremia .

    6 months

Interventions

procalcitonin measurementDIAGNOSTIC_TEST

For each patient were blood cultures were taken, a procalcitonin level was determined

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Patients admitted to the ICU whom blood cultures are taken for suspected bacterial infection.

You may qualify if:

  • Patients admitted to the ICU
  • Age \> 18 years

You may not qualify if:

  • Hemodialysis/ Continuous Veno-Venous Hemofiltration

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Rijnstate hospital

Arnhem, Gelderland, Netherlands

Location

MeSH Terms

Conditions

Sepsis

Condition Hierarchy (Ancestors)

InfectionsSystemic Inflammatory Response SyndromeInflammationPathologic ProcessesPathological Conditions, Signs and Symptoms

Study Officials

  • H.J. van Leeuwen

    Rijnstate Hospital

    STUDY CHAIR

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
RETROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

March 28, 2018

First Posted

April 13, 2018

Study Start

October 1, 2017

Primary Completion

January 1, 2019

Study Completion

March 1, 2019

Last Updated

June 21, 2024

Record last verified: 2024-06

Locations

NL(1)